← SynDRA
AMCENESTRANT
SynDRA canonical compound SYN0039896 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ESR1 |
|---|
| Indication | breast cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- ESR1 DEGRADER
- ESR1 ANTAGONIST
Cross-references
Synonyms
- SAR439859
- SAR-439859
- Amcenestrant [INN]
- Amcenestrant [USAN]
- TBF1NHY02O
- UNII-TBF1NHY02O
- AMCENESTRANT [JAN]
- AMCENESTRANT [WHO-DD]
- RefChem:111883
- Selective Estrogen Receptor Degrader SAR439859
- Selective Estrogen Receptor Downregulator SAR439859
- Amcenestrant [USAN:INN]
- C31H30Cl2FNO3
- Amcenestrant (JAN/USAN/INN)
- orb1309128
- SCHEMBL19131426
- SCHEMBL29357604
- SCHEMBL29421167
- US9714221, Example 51
- BDBM263716
- GLXC-21690
- EX-A4678
- NSC827675
- s9609
- WHO 11312
- AKOS040737414
- NSC-827675
- SAR-439859?
- NCGC00842080-01
- DA-70753
- MS-30114
- HY-133017
- CS-0109407
- D12145
- G17358
- T12832
- L5B
Look up AMCENESTRANT in the interactive SynDRA portal →